The five prognostic DCLs tended to condense around the well-known cancer gene ESPL1, and the transcriptional synchrony between ESPL1 and PTTG1 (another well-known cancer gene) tended to be elevated in patients of adverse prognosis. The gene discussed is ESPL1; the disease is cancer.